로딩 중…
지수 로딩 중…
Legend Biotech Corporation
LEGN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$19.01+2.48%
2026-08-03
Financials
Valuation Metrics
Legend Biotech Corporation's Market Cap is $3.53B. At end of 2025 it was $4.02B. Ranked #1656 of 3,111 in US market (top 53%), #587 of 1,445 on NASDAQ (top 41%), #97 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 36%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.53B | US#1,656/3,111 Sec#97/269 |
| Revenue | $1.14B | US#1,865/3,111 Sec#50/269 |
| Net Income | $-250M | US—/3,111 Sec—/269 |
| Total Assets | $1.60B | US#2,214/3,111 Sec#63/269 |
| Net Assets | $968M | US#1,805/3,111 Sec#66/269 |
| Value | ||
| P/B | 3.65x | US#1,868/3,111 Sec#112/269 |
| P/S | 3.10x | US#1,780/3,111 Sec#50/269 |
| FCF Yield | -6.69% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -25.85% | US#2,580/3,111 Sec#117/269 |
| ROA | -15.67% | US#2,734/3,111 Sec#115/269 |
| Op. Margin | -11.92% | US#2,656/3,111 Sec#103/269 |
| Revenue Growth | 56.42% | US#262/3,111 Sec#50/269 |
| Financial Health | ||
| Debt Ratio | 65.00% | US#729/3,111 Sec#152/269 |
| Total Debt | $389M | US#1,965/3,111 Sec#67/269 |
| FCF | $-236M | US#2,761/3,111 Sec#226/269 |
| Cash | $646M | US#905/3,111 Sec#45/269 |
| Current Ratio | 2.13x | US#1,170/3,111 Sec#224/269 |
| Performance | ||
| 1Y Return | -51.01% | US#2,980/3,111 Sec#248/269 |
| 1M Return | -36.44% | US#3,079/3,111 Sec#264/269 |
| From 52W High | -51.46% | US#2,800/3,111 Sec#225/269 |
| 1Y MDD | -62.43% | US#2,776/3,111 Sec#223/269 |
| Trading | ||
| Volume | 1,524,380 shares | US#691/3,111 Sec#56/269 |
| Trading Value | $29M | US#1,345/3,111 Sec#85/269 |
| Per Share | ||
| EPS | $-1.61 | US—/3,111 Sec—/269 |
| BPS | $5.42 | US#2,195/3,111 Sec#129/269 |